Stem cell therapy for Back & Disc Degeneration — for patients from United Kingdom

If you are researching Back & Disc Degeneration treatment from the United Kingdom, the obstacle is usually access or cost: standard options have plateaued, and regenerative therapy at home runs to €4,640–€46,400. Stem Plus offers the same European GMP standard for a fraction of that — and an easy, mostly visa-free trip.

How Back & Disc Degeneration is treated

Chronic back pain frequently stems from degenerative disc disease—loss of hydration and structural integrity in intervertebral discs—compounded by facet joint arthritis and paraspinal muscle atrophy. Stem cell strategies target the nucleus pulposus (disc centre), where placental mesenchymal stem cells (MSCs) may regenerate proteoglycan matrix and restore biomechanical function. Exosomes derived from stem cells penetrate the avascular disc environment and deliver anti-inflammatory proteins that suppress catabolic pathways. Unlike surgical fusion, which immobilises segments, cell-based approaches aim to restore disc biology whilst preserving motion. MSCs also modulate neuropathic pain via immune suppression, addressing pain signalling independent of structural restoration. Thirty-five registered trials globally investigate disc regeneration and pain outcomes; two actively recruit new participants. It is delivered under a physician-led protocol and designed to complement your existing care.

Your cost from United Kingdom

Cost ranges are indicative market figures for planning, not quotes.